These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6752290)

  • 21. Human epidermal cells synthesize HLA-DR alloantigens in vitro upon stimulation with gamma-interferon.
    Volc-Platzer B; Leibl H; Luger T; Zahn G; Stingl G
    J Invest Dermatol; 1985 Jul; 85(1):16-9. PubMed ID: 3159800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative evaluation of two distinct cell populations expressing HLA-DR antigens in normal human epidermis.
    Dezutter-Dambuyant C; Cordier G; Schmitt D; Faure M; Laquoi C; Thivolet J
    Br J Dermatol; 1984 Jul; 111(1):1-11. PubMed ID: 6204670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnesium ions inhibit the antigen-presenting function of human epidermal Langerhans cells in vivo and in vitro. Involvement of ATPase, HLA-DR, B7 molecules, and cytokines.
    Schempp CM; Dittmar HC; Hummler D; Simon-Haarhaus B; Schulte-Mönting J; Schöpf E; Simon JC
    J Invest Dermatol; 2000 Oct; 115(4):680-6. PubMed ID: 10998143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of epidermal Langerhans cells.
    Morhenn VB; Pfendt EA
    Methods Enzymol; 1984; 108():357-62. PubMed ID: 6396484
    [No Abstract]   [Full Text] [Related]  

  • 25. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens).
    Hanau D; Fabre M; Schmitt DA; Garaud JC; Pauly G; Tongio MM; Mayer S; Cazenave JP
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2901-5. PubMed ID: 3106979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of class II HLA antigens (HLA-DR, DQW1, DQW3) in normal skin and cutaneous pathology].
    Gomes M; Schmitt D; Dezutter-Dambuyant C; Capra JD; Thivolet J
    Pathol Biol (Paris); 1986 Mar; 34(3):157-64. PubMed ID: 3517784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
    Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
    J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
    Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
    J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations.
    Czernielewski J; Faure M; Schmitt D; Thivolet J
    Clin Exp Immunol; 1982 Nov; 50(2):426-33. PubMed ID: 6217936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrastructural documentation of HLA-DR antigen reactivity in normal human acrosyringial epithelium.
    Murphy GF; Shepard RS; Harrist TJ; Bronstein BR; Bhan AK
    J Invest Dermatol; 1983 Aug; 81(2):181-3. PubMed ID: 6348181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell surface expression of invariant gamma-chain of class II histocompatibility antigens in human skin.
    Claesson-Welsh L; Scheynius A; Tjernlund U; Peterson PA
    J Immunol; 1986 Jan; 136(2):484-90. PubMed ID: 2416807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential distribution of Langerhans cells in organ culture of human skin.
    Elmets CA; Bergstresser PR; Streilein JW
    J Invest Dermatol; 1982 Nov; 79(5):340-5. PubMed ID: 6215452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells.
    Meunier L; Gonzalez-Ramos A; Cooper KD
    J Immunol; 1993 Oct; 151(8):4067-80. PubMed ID: 8409386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells.
    Berman B; Duncan MR; Smith B; Ziboh VA; Palladino M
    J Invest Dermatol; 1985 Jan; 84(1):54-8. PubMed ID: 2578172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased number and function of antigen-presenting cells in the skin following application of irritant agents: relevance for skin cancer?
    Lisby S; Baadsgaard O; Cooper KD; Vejlsgaard GL
    J Invest Dermatol; 1989 Jun; 92(6):842-7. PubMed ID: 2786039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous T-cell lymphoma lesional epidermal cells activate autologous CD4+ T lymphocytes: involvement of both CD1+OKM5+ and CD1+OKM5- antigen-presenting cells.
    Hansen ER; Baadsgaard O; Lisby S; Cooper KD; Thomsen K; Vejlsgaard GL
    J Invest Dermatol; 1990 Apr; 94(4):485-91. PubMed ID: 1968933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of HLA-DR antigen in skin from patients with psoriasis.
    Morhenn VB; Abel EA; Mahrle G
    J Invest Dermatol; 1982 Feb; 78(2):165-8. PubMed ID: 6173446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.